Reuters logo
1 年前
BRIEF-Cascadian Therapeutics announces approval of Tucatinib for lead product candidate ONT-380
2016年8月31日 / 晚上8点27分 / 1 年前

BRIEF-Cascadian Therapeutics announces approval of Tucatinib for lead product candidate ONT-380

Aug 31 (Reuters) - Cascadian Therapeutics Inc

* Cascadian Therapeutics announces approval of nonproprietary name "Tucatinib" for lead product candidate ONT-380 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below